Abstract
Animal models are needed along the development and evaluation of potential chemotherapeutic agents against leishmaniasis. Infections of Syrian hamsters with Leishmania species causing visceral leishmaniasis (VL) closely mimic the disease in the natural hosts, including target organs, lesions, and clinical course. Therefore, despite some shortcomings (e.g., genetic background, price, and scarcity of reagents), it is probably the best laboratory rodent model of VL. However, handling of hamsters can be technically challenging because of their particular anatomy. Here, we describe in detail four different routes to establish an experimental VL in the hamster model using Leishmania promastigotes and amastigotes. Each route requires various manipulations and has different benefits and drawbacks. Choice of the most suitable route should be made by the researcher in accordance with the specific plan and purpose of the study.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Nagle AS, Khare S, Kumar AB, Supek F, Buchynskyy A, Mathison C, Chennamaneni NK, Pendem N, Buckner FS, Gelb MH, Molteni V (2014) Recent developments in drug discovery for Leishmaniasis and human African Trypanosomiasis. Chem Rev 114(22):11305–11347
World Health Organization (2010) Control of Leishmaniases. Technol Rep Ser 949:1–186
Corral-Caridad MJ, Alunda JM (2013) Chemotherapy of leishmaniasis: a veterinary perspective. In: Jäger T, Koch O, Flohé L (eds) Trypanosomatid diseases. Molecular routes to drug discovery. Wiley-VCH, Weinheim, pp 17–36
Nishi GS (2011) Visceral leishmaniasis: experimental models for drug discovery. Indian J Med Res 133(1):27–39
Hommel M, Jaffe CL, Travi B, Milon G (1995) Experimental models for leishmaniasis and for testing anti-leishmanial vaccines. Ann Trop Med Parasitol 89(Suppl 1):55–73
Melby PC, Chandrasekar B, Zhao W, Coe JE (2001) The hamster as a model of human visceral Leishmaniasis: progressive disease and impaired generation of nitric oxide in the face of a prominent Th1-like cytokine response. J Immunol 166:1912–1920
Sacks DL, Perkins PV (1984) Identification of an infective stage of Leishmania promastigotes. Science 223(4643):1417–1419
Bates PA (1993) Complete developmental cycle of Leishmania mexicana in axenic culture. Parasitology 108:1–9
Gonzaga M, Laranjeira MF, Andrade R, Marino R, Floeter-Winter LM (2011) Correlation of meta 1 expression with culture stage, cell morphology and infectivity in Leishmania (Leishmania) amazonensis promastigotes. Mem Inst Oswaldo Cruz 106(2):190–193
Silva AM, Cordeiro-da-Silva A, Coombs GH (2011) Metabolic variation during development in culture of Leishmania donovani promastigotes. PLoS Negl Trop Dis 5(12):e1451
Moreira N, Vitoriano-Souza J, Roatt BM, Vieira PM, Ker HG, de Oliveira Cardoso JM, Giunchetti RC, Carneiro CM, de Lana M, Reis AB (2012) Parasite burden in hamsters infected with two different strains of Leishmania (Leishmania) infantum: “Leishman Donovan units” versus real-time PCR. PLoS One 7(10):e47907
Wyllie S, Fairlamb AH (2006) Refinement of techniques for the propagation of Leishmania donovani in hamsters. Acta Trop 97:364–369
Moreira ND, Vitoriano-Souza J, Roatt BM, Vieira PM, Coura-Vital W, Cardoso JM, Rezende MT, Ker HG, Giunchetti RC, Carneiro CM, Reis AB (2016) Clinical, hematological and biochemical alterations in hamster (Mesocricetus auratus) experimentally infected with Leishmania infantum through different routes of inoculation. Parasit Vectors 31(9):181
Kaur S, Kaur T, Garg N, Mukherjee S, Raina P, Athokpam V (2008) Effect of dose and route of inoculation on the generation of CD4+ Th1/Th2 type of immune response in murine visceral leishmaniasis. Parasitol Res 103:1413
Spath GF, Beverley SM (2001) A lipophosphoglycan-independent method for isolation of infective Leishmania metacyclic promastigotes by density gradient centrifugation. Exp Parasitol 99:97–103
Lei SM, Romine NM, Beetham JK (2010) Population changes in Leishmania chagasi promastigote developmental stages due to serial passage. J Parasitol 96(6):1134–1138
Flecknell P, Lofgren J, Dyson M, Marini R, Swindle M (2015) Preanesthesia, Anesthesia, analgesia and euthanasia. In: Fox JG (ed) Laboratory animal medicine. Academic Press-Elsevier, London, pp 1135–1200
U.S. Department of Health and Human Services (2009) Section VIII-C: parasitic agents. In: Biosafety in microbiological and biomedical laboratories. HHS Publication No. (CDC) 21–1112: 182–194
Acknowledgments
This work has been partially funded by the European Union’s Seventh Framework Programme for research, technological development, and demonstration under grant agreement no. 603240 (NMTrypI—New Medicines for Trypanosomatidic Infections). http://www.nmtrypi.eu/. Collaboration with Evidence-Based Advisors (P + 3A) is acknowledged.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Jiménez-Antón, M.D., Grau, M., Olías-Molero, A.I., Alunda, J.M. (2019). Syrian Hamster as an Advanced Experimental Model for Visceral Leishmaniasis. In: Clos, J. (eds) Leishmania. Methods in Molecular Biology, vol 1971. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-9210-2_17
Download citation
DOI: https://doi.org/10.1007/978-1-4939-9210-2_17
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-9209-6
Online ISBN: 978-1-4939-9210-2
eBook Packages: Springer Protocols